Simplex Trading
AVIR icon

Simplex Trading’s Atea Pharmaceuticals AVIR Stock Holding History

Simplex Trading’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.7K Buy
4,600
+1,900
+70% +$8.73K ﹤0.01% 6593
2025
Q4 		$9.64K Buy
2,700
+400
+17% +$1.27K ﹤0.01% 7007
2025
Q3 		$6K Buy
2,300
+300
+15% +$1.02K ﹤0.01% 8156
2025
Q2 		$7K Sell
2,000
-1,400
-41% -$4.17K ﹤0.01% 7526
2025
Q1 		$10K Sell
3,400
-13,900
-80% -$43.4K ﹤0.01% 7070
2024
Q4 		$57K Buy
17,300
+1,800
+12% +$5.98K ﹤0.01% 5739
2024
Q3 		$51K Sell
15,500
-2,400
-13% -$8.7K ﹤0.01% 5854
2024
Q2 		$59K Buy
17,900
+7,500
+72% +$28K ﹤0.01% 5903
2024
Q1 		$42K Buy
+10,400
New +$40.7K ﹤0.01% 6408
2023
Q3 		– Sell
-1,100
Closed -$4K – 8630
2023
Q2 		$4K Sell
1,100
-9,900
-90% -$37.1K ﹤0.01% 8004
2023
Q1 		$36K Sell
11,000
-230,600
-95% -$935K ﹤0.01% 6282
2022
Q4 		$1.16M Sell
241,600
-66,800
-22% -$338K ﹤0.01% 2325
2022
Q3 		$1.75M Buy
308,400
+29,800
+11% +$228K ﹤0.01% 2074
2022
Q2 		$1.98M Buy
278,600
+243,800
+701% +$1.66M ﹤0.01% 1879
2022
Q1 		$251K Sell
34,800
-12,900
-27% -$87.6K ﹤0.01% 4804
2021
Q4 		$426K Buy
47,700
+42,200
+767% +$658K ﹤0.01% 4038
2021
Q3 		$117K Hold
5,500
– – ﹤0.01% 6391
2021
Q2 		$118K Buy
5,500
+5,471
+18,866% +$164K ﹤0.01% 6483
2021
Q1 		$179K Buy
+29
New +$1.96K ﹤0.01% 4910

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Simplex Trading's AVIR Position: Q1 2026 in Review

Simplex Trading increased its Atea Pharmaceuticals (AVIR) stake by 229% in Q1 2026, buying an estimated $20K and bringing the position to 6,244 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6272.

Simplex Trading first reported a position in AVIR in Q4 2021 and has held it in 14 quarters since. The position peaked at $847K in Q1 2022. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Simplex Trading held 6,244 shares of Atea Pharmaceuticals worth $33.6K as of Q1 2026.
  • Simplex Trading bought 4,349 Atea Pharmaceuticals shares in Q1 2026, an estimated $20K.
  • Atea Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6272 holding.
  • Simplex Trading first reported a position in Atea Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
  • Simplex Trading's Atea Pharmaceuticals position peaked at $847K in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.